Lipids in Blood Predict Nerve Damage Risk Among Patients With Type 2 Diabetes

The findings open up potential to test for biomarkers and facilitate more focused management of patients with the condition.

Russell N. DeJong Professor of Neurology

Professor, Neurology

Director, ALS Center of Excellence

Director, NeuroNetwork for Emerging Therapies